GCA
Greenwood Capital Associates’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.27M | Sell |
314,305
-62,726
| -17% | -$1.05M | 0.66% | 54 |
|
|
2025
Q1 | $5.79M | Buy |
377,031
+143,506
| +61% | +$2.21M | 0.78% | 40 |
|
|
2024
Q4 | $5.15M | Sell |
233,525
-3,240
| -1% | -$71.4K | 0.67% | 50 |
|
|
2024
Q3 | $4.27M | Buy |
+236,765
| New | +$4.27M | 0.56% | 60 |
|
|
2019
Q1 | – | Sell |
-42,760
| Closed | -$659K | – | 205 |
|
|
2018
Q4 | $659K | Buy |
42,760
+11,125
| +35% | +$171K | 0.17% | 83 |
|
|
2018
Q3 | $682K | Buy |
+31,635
| New | +$682K | 0.15% | 88 |
|
|
2017
Q4 | – | Sell |
-37,032
| Closed | -$652K | – | 236 |
|
|
2017
Q3 | $652K | Buy |
+37,032
| New | +$652K | 0.16% | 96 |
|